Mark S. Blumenkranz
HJ Smead Professor in the Department of Ophthalmology at Stanford University. He received his undergraduate/graduate degree in biochemical pharmacology, and medical education at Brown University and vitreo-retinal training at Bascom Palmer where he served on the faculty. He was founding director of the vitreoretinal fellowship program at William Beaumont Hospital & Chairman of the Department at Stanford from 1997 until 2015. He spearheaded the development of the Byers Eye Institute at Stanford and served as founding Director from 2010 until 2015. Dr. Blumenkranz was an early innovator in vitrectomy techniques to treat complex forms of retinal detachment as well as the treatment of macular disease. He helped usher in the modern era of intravitreal, gene and surgical adjuvant drug therapy, new lasers and laser tissue interactions.
modern era of intravitreal, gene and surgical adjuvant drug therapy